This law puts limits on credit card fees, makes statements more transparent and sharply reduced the marketing of credit cards to young people.

The combined force of the Inflation Reduction Act’s drug price negotiation programme and the 2025 Executive Order on Most-Favoured-Nation pricing marks a pivotal shift in US pharmaceutical policy.